This detoxifying effect can improve skin clarity and reduce the risk of acne and other skin conditions
TRIUMPH-1's prespecified 104-week extension (BMI 35 subgroup) showed average weight loss reaching 30.3% higher than the 28.3% at week 80
Patients reported, in interview forms, using the following drugs: brinzolamide, latanoprost, ripasudil, travoprost, carteolol, isopropyl unoprostone, tafluprost, timolol, bunazosin, bimatoprost, brimonidine, bromfenac, gatifloxacin, levofloxacin, phenylephrine and tropicamide
Splitting a 12mg weekly dose into two 6mg injections (for example Monday and Thursday) reduces peak plasma concentration and can significantly reduce gastrointestinal side effects